scholarly article | Q13442814 |
P2093 | author name string | Christine A Haller | |
Peyton Jacob | |||
Neal Benowitz | |||
Minjing Duan | |||
P2860 | cites work | Psychophysical bases of perceived exertion | Q29615667 |
Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids | Q33928222 | ||
Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis | Q34188002 | ||
Hemodynamic effects of ephedra-free weight-loss supplements in humans | Q34451168 | ||
Coffee consumption and risk of type 2 diabetes: a systematic review | Q36184343 | ||
Coffee, diabetes, and weight control | Q36615589 | ||
Influence of exercise on the pharmacokinetics of drugs | Q37944766 | ||
Effect of caffeine and ephedrine ingestion on anaerobic exercise performance | Q43688835 | ||
An acute oral dose of caffeine does not alter glucose kinetics during prolonged dynamic exercise in trained endurance athletes | Q43739713 | ||
Effect of ingesting caffeine and ephedrine on 10-km run performance | Q43877137 | ||
Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women | Q44138662 | ||
Short-term metabolic and hemodynamic effects of ephedra and guarana combinations | Q46375058 | ||
Comparison of caffeine and theophylline ingestion: exercise metabolism and endurance. | Q54134183 | ||
Performance and metabolic responses to a high caffeine dose during prolonged exercise | Q55044504 | ||
What is the dose-response relationship between exercise training and blood pressure? | Q56955080 | ||
Effects of caffeine, fructose, and glucose ingestion on muscle glycogen utilization during exercise | Q68543423 | ||
Effects of physical activity and immobilization on plasma digoxin concentration and renal digoxin clearance | Q71823225 | ||
From the Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products--Texas, December 1993-September 1995 | Q71826026 | ||
Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exercise | Q73892759 | ||
Gastrointestinal function during exercise: comparison of water, sports drink, and sports drink with caffeine | Q74218061 | ||
Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise | Q74485761 | ||
Gastric emptying as a regulatory factor in fluid uptake | Q77051557 | ||
Effect of caffeine on metabolism, exercise endurance, and catecholamine responses after withdrawal | Q77369311 | ||
Caffeine, performance, and metabolism during repeated Wingate exercise tests | Q77369315 | ||
Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test | Q77386186 | ||
Thermal regulation in the heat during exercise after caffeine and ephedrine ingestion | Q77894434 | ||
The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men | Q83154471 | ||
Metabolic and exercise endurance effects of coffee and caffeine ingestion | Q93911870 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
P304 | page(s) | 833-840 | |
P577 | publication date | 2008-03-13 | |
P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
P1476 | title | Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions | |
P478 | volume | 65 |
Q42373405 | (R,R)-Disynephrine ether bis-(hydrogen sulfate). |
Q37831732 | A review of psychophysiological stressors on pharmacokinetics. |
Q24599282 | A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine |
Q26825630 | A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects |
Q47908750 | Acute consumption of p-synephrine does not enhance performance in sprint athletes. |
Q42282816 | Acute p-synephrine ingestion increases fat oxidation rate during exercise |
Q38163000 | An evidence-based systematic review of bitter orange (Citrus aurantium) by the Natural Standard Research Collaboration |
Q46584274 | Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial |
Q45414530 | Cardiovascular toxicity of Citrus aurantium in exercised rats |
Q38984887 | Combined Effects of Phytochemicals and Exercise on Fatty Acid Oxidation |
Q48051885 | Dose-Response Effects of p-Synephrine on Fat Oxidation Rate During Exercise of Increasing Intensity |
Q34648247 | Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans |
Q34893795 | Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes |
Q34477293 | Efficacy and Safety of White Willow Bark (Salix alba) Extracts |
Q83450530 | Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium |
Q55554417 | Lack of Evidence that p-Synephrine is Responsible for STEMI. |
Q86006902 | Multiple dosing of ephedra-free dietary supplements: hemodynamic, electrocardiographic, and bacterial contamination effects |
Q38921732 | Phytochemical compounds in sport nutrition: Synephrine and hydroxycitric acid (HCA) as examples for evaluation of possible health risks |
Q46262928 | Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study |
Q38655858 | Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine |
Q47156955 | Scientific Opinion on the safety of caffeine |
Q39532815 | The Effects of Supplementation with p-Synephrine Alone and in Combination with Caffeine on Metabolic, Lipolytic, and Cardiovascular Responses during Resistance Exercise |
Q57570291 | The action of p-synephrine on hepatic carbohydrate metabolism and respiration occurs via both Ca2+-mobilization and cAMP production |
Q47683541 | The effect of operational stressors on ibuprofen pharmacokinetics |
Q36069351 | The effects of supplementation with P-Synephrine alone and in combination with caffeine on resistance exercise performance |
Q90448229 | The influence of citrus aurantium and caffeine complex versus placebo on the cardiac autonomic response: a double blind crossover design |
Q37863654 | The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine |
Q47322199 | Toxicological effects of a mixture used in weight loss products: p-synephrine associated with ephedrine, salicin, and caffeine. |
Q52842935 | [Risk assessment of synephrine in dietary supplements]. |
Q89891932 | p-Synephrine, ephedrine, p-octopamine and m-synephrine: Comparative mechanistic, physiological and pharmacological properties |
Search more.